Know About New Trends and Technological Advancements in Immunoassay
Immunoassay is a precise bioanalytical method which measures the presence of analytes extending from small molecules to macromolecules in a solution with the use of an antibody or an antigen as a biorecognition agent. This method has been examined by the various market players to accomplish exceptional precision by the broad discovery in the product design and innovations. Various recent technological developments are marked in the evolution of immunoassay techniques over the past few years.
Immunoassay is used to measure the concentration of small molecules such as lipids, protein, nucleic acids, etc. in solutions using antigen-antibody reactions. It is majorly used to detect several infectious disorders like dengue, hepatitis, human immunodeficiency virus (HIV). Increasing incidences of infectious diseases such as HIV is the primary global public health issue. In 2018, the World Health Organization (WHO) having claimed that more than 32 million HIV people are diagnosed, out of which 770,000 people died. At the end of 2018, around 1.7 million people were reported to be newly infected globally, including 62% of adults and 54% of children. According to the HIV and AIDS organization (AVERT), in 2018, 1.1 million U.S. residents were infected with HIV, whereas APAC registered 5.2 million HIV-infected population. According to the European CDC, ~2 million people in Europe were infected with HIV in 2018.
New technologies or products are being refined and improved to provide more comfortable to use devices with incremental improvements in analytical performance. For instance, in April 2019, Thermo Fisher Scientific launched the CEDIA mitragynine (Kratom) Assay, the latest drugs of abuse test, which include supporting calibrators and controls. This test is majorly performed for criminal justice and forensic use only. Thus, the innovative steps and technological advancements undertaken by new entrants as well as established market players, improves the quality and efficacy of immunoassay tests and is expected to favor the growth of the market during the forecast period.